[The clinico-bacteriological and pharmacokinetic evaluation of vancomycin in clinical practice].
Clinical application of vancomycin in 24 patients produced a response in 83.3% of the patients. The drug was active against pneumococcal pneumonia, bronchitis, staphylococcal endocarditis and mastitis. Positive pharmacokinetic parameters of the drug allows introduction of the antibiotic 1-2 times daily.
Orlov
V A
VA
Sokolova
V I
VI
Shenderovich
V A
VA
Troshina
E V
EV
D000208:Acute Disease; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy; D002908:Chronic Disease; D006801:Humans; D008826:Microbial Sensitivity Tests; D013997:Time Factors; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology*
D014640:Vancomycin
Kliniko-bakteriologicheskaia i farmakokineticheskaia otsenka vankomitsina v klinicheskoĭ praktike.